SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-20-003020
Filing Date
2020-04-29
Accepted
2020-04-29 16:15:14
Documents
4
Period of Report
2020-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_042920.htm 8-K 25356
2 EXHIBIT 10.1 exh_101.htm EX-10.1 111437
3 EXHIBIT 99.1 exh_991.htm EX-99.1 9236
4 GRAPHIC logo.jpg GRAPHIC 2204
  Complete submission text file 0001171843-20-003020.txt   150694
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 20830484
SIC: 3841 Surgical & Medical Instruments & Apparatus